Weekly somatrogon maintains growth in children with growth hormone deficiency, suggesting a promising alternative to daily therapy.
Weekly somatrogon maintains growth-promoting effects comparable to daily GH therapy in pediatric patients with GHD. Patients' adherence and satisfaction contribute to making this therapy a valid alternative to daily treatments.
No takes yet. Share an insight, caveat, or question.
Giusto et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: